CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Curium prices generic radioligand at 5% discount to Novartis' Lutathera

BexlutryLutatheraNegative
AI Analysis

Summary

Curium announced the list price of Bexlutry, its radiosimilar to Novartis' Lutathera, at $63,524 per infusion, representing approximately 5% discount to Novartis' drug.

Importance:3/10
Sentiment:
-0.40
pricingcompetitiongeneric/radiosimilaroncology
Related Companies

Read the original article

Published by Endpoints News on October 9, 2026 6:28 PM

Read Original